Orion Portfolio Solutions, LLC - IMMUNOPRECISE ANTIBODIES LTD ownership

Back to all holdings Add to watchlist

IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 15 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Orion Portfolio Solutions, LLC ownership history of IMMUNOPRECISE ANTIBODIES LTD
ValueSharesWeighting
Q2 2021$85,000
-48.8%
14,111
-16.3%
0.00%
-57.1%
Q1 2021$166,000
-30.0%
16,867
+6.6%
0.01%
-36.4%
Q4 2020$237,000–15,821–0.01%–
 Download
Other shareholders
IMMUNOPRECISE ANTIBODIES LTD shareholders Q4 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 1,058,035$2,9310.15%
Gradient Capital Advisors, LLC 26,808$74,2580.03%
WEST PACES ADVISORS INC. 1,665$4,6120.00%
DIMENSIONAL FUND ADVISORS LP 28,652$79,3660.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 17,484$48,4300.00%
CITIGROUP INC 7$190.00%
MORGAN STANLEY 533$1,4760.00%
NATIONAL BANK OF CANADA /FI/ 2,255$6,2510.00%
WOLVERINE TRADING, LLC 11,700$330.00%
View complete list of IMMUNOPRECISE ANTIBODIES LTD shareholders